Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adding beta-2 agonism does not improve beta-1 blockade exercise responses in hypertensives

P A Rueckert1, P R Slane, P Hanson

  • 1Department of Medicine, University of Wisconsin Medical School, Madison 53792-3248.

Medicine and Science in Sports and Exercise
|August 1, 1994
PubMed
Summary

Celiprolol, a beta-blocker, reduced resting vascular resistance but did not improve exercise performance compared to atenolol. Beta-2 agonism offers no exercise advantage over beta-1 blockade in hypertensive men.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A pilot study to assess the feasibility and uptake of MindDEC, a mindfulness-based self-management course for type 2 diabetes.

Complementary therapies in medicine·2024
Same author

Post-stroke fatigue: how it relates to motor fatigability and other modifiable factors in people with chronic stroke.

Acta neurologica Belgica·2020
Same author

First Report of the Occurrence of Tomato chlorosis virus and Tomato infectious chlorosis virus in Taiwan.

Plant disease·2019
Same author

Exercise Testing Update.

The Physician and sportsmedicine·2016
Same author

Painful fat necrosis resulting from insulin injections.

Endocrinology, diabetes & metabolism case reports·2014
Same author

Fast shut-down protection system for radio frequency breakdown and multipactor testing.

The Review of scientific instruments·2014

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Pharmacology

Background:

  • Beta-1 adrenoceptor antagonists are standard hypertension treatment.
  • Celiprolol combines beta-1 antagonism with beta-2-mediated vasodilation.
  • The impact of celiprolol on exercise performance in hypertensive individuals requires clarification.

Purpose of the Study:

  • To compare the effects of celiprolol and atenolol on resting vascular resistance and exercise performance.
  • To test if celiprolol's beta-2 vasodilation improves exercise capacity compared to a selective beta-1 antagonist.

Main Methods:

  • A 6-week crossover study involving 11 untrained hypertensive men.
  • Participants received celiprolol, atenolol, or placebo.
  • Measurements included resting vascular resistance and submaximal/maximal bicycle ergometry.

Related Experiment Videos

Main Results:

  • Celiprolol significantly decreased resting forearm and calf vascular resistance; atenolol had no significant effect.
  • Neither drug altered submaximal exercise oxygen uptake or perceived exertion.
  • Both celiprolol and atenolol similarly reduced peak oxygen uptake compared to placebo.

Conclusions:

  • Celiprolol reduces resting vascular resistance more than atenolol.
  • Beta-2 agonism combined with beta-1 antagonism does not enhance exercise performance over conventional beta-1 blockade.
  • Other factors during exercise may override beta-2-mediated vasodilation under beta-blockade.